Why it matters: Forerunner's backing of a founder who ran a $2B seller network shows how commerce investors are betting on AI that decides what to promote, not just drafts the copy.
Why it matters: Scimplify's round shows how AI agents are being applied to specialty chemicals and critical materials, with revenue and customer numbers that indicate real commercial traction.
Why it matters: Ambio's seed round shows how AI matchmaking is being applied to the demand side of recycled plastics, where weak buyer interest has stalled the market.
Why it matters: Pluto Security's $42M raise shows how AI agent discovery and policy-based containment are becoming a distinct enterprise security category.
Why it matters: Causa Prima's two-sided agent network for invoice disputes shows how AI finance startups are moving from single-company tools to cross-company settlement.
Why it matters: Scuba's context engine shows how a shared data layer plus an MCP server can feed Claude, ChatGPT and Cursor without manual prompt assembly.
Allara raised a $30M round, bringing total funding to $75M, with existing investors Index Ventures and GV increasing their commitments and Camino Partners.
Why it matters: Allara's $30M round and its plan to push AI from intake through treatment show how an insurance-covered virtual clinic intends to scale specialty care.
Why it matters: Loops' seed round and its five-part agentic commerce stack show how retailers are consolidating fragmented AI tools into one journey layer.
Why it matters: Ambi's launch shows an ambient agent that listens across Apple devices and hands recurring work to multiple agents, with a wearable planned next.
Why it matters: Ubitium's €14M seed and 2027 UB410 sampling plan show how physical-AI chip startups are consolidating DSP, NPU and CPU work onto one array.
Why it matters: Sainaptic's £1M pre-seed shows investors backing AI exam grading with sub-1% deviation, a concrete data point on where edtech funding is going.
Why it matters: Scarlet's $50M round shows how AI medical device certification is becoming its own business, with named customers and a regulatory bottleneck spelled out.
Why it matters: TypeSafe's $870M round at a $7.5B valuation weeks after Jev's launch shows how fast enterprise buyers are testing non-LLM automation models.
Polyphron raised $20M in seed funding led by Quiet Capital, with Haystack, Gradient and Compound participating. The New York company grows donor-defined human tissue in an automated lab.
Why it matters: The interview details how Polyphron pairs lab-grown human tissue with longitudinal data to train predictive models, a concrete look at the tissue-as-verification layer for drug testing.
Why it matters: Gudea's seed round shows investors backing narrative-prediction software that maps how stories spread across platforms rather than tracking keywords.
Why it matters: Vesta's $30M round shows mortgage lenders adopting AI agents for loan origination, with revenue up 12x year over year and under 5% market share.